Changes in classical and nonclassicalHLA class I antigen and NK cell-activating ligand expression have been identified in malignant lesions.
2
A protective role against NK cells equipped of suitable inhibitory receptors has been proposed for nonclassicalHLA-class I molecules including HLA-E and HLA-G.